GTHP GUIDED THERAPEUTICS INC revenue, earnings and financials

For the quarter ended June 30, 2026, GUIDED THERAPEUTICS INC reported revenue of $0 (down 100.0% from a year earlier), net income of −$605K and diluted EPS of −$0.01; over the last four quarters revenue was $650K and net income −$3.06M; for the fiscal year ended December 2025 revenue was $767K, up 10857.1% on the year before.

GTHP annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $767K, gross profit $571K, operating income −$2.37M, net income −$3.20M (margin -416.7%), EPS −$0.04
• Fiscal year ended Dec 2024: revenue $7.00K, gross profit $2.00K, operating income −$2.11M, net income −$2.42M (margin -34528.6%), EPS −$0.05
• Fiscal year ended Dec 2023: revenue $98.0K, gross profit $36.0K, operating income −$3.46M, net income −$3.49M (margin -3560.2%), EPS −$0.07
• Fiscal year ended Dec 2022: revenue $13.0K, gross profit −$68.0K, operating income −$3.33M, net income −$4.34M (margin -33392.3%), EPS −$0.15
• Fiscal year ended Dec 2021: revenue $81.0K, gross profit $20.0K, operating income −$2.36M, net income −$2.07M (margin -2555.6%), EPS −$0.18

GTHP quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $0 (down 100.0% year over year), net income −$605K, EPS −$0.01
• Quarter ended Mar 31, 2026: revenue $0, net income −$500K, EPS −$0.01
• Quarter ended Dec 31, 2025 (from the annual report): revenue $590K (up 58900.0% year over year), net income −$1.22M, EPS −$0.01
• Quarter ended Sep 30, 2025: revenue $60.0K, net income −$742K, EPS −$0.01
• Quarter ended Jun 30, 2025: revenue $117K, net income −$811K, EPS −$0.01
• Quarter ended Mar 31, 2025: revenue $0 (down 100.0% year over year), net income −$427K, EPS −$0.01
• Quarter ended Dec 31, 2024 (from the annual report): revenue $1.00K (down 96.9% year over year), net income −$1.05M, EPS −$0.02
• Quarter ended Sep 30, 2024: revenue $0, net income −$654K, EPS −$0.01
• Quarter ended Jun 30, 2024: revenue $0 (down 100.0% year over year), net income −$709K, EPS −$0.01
• Quarter ended Mar 31, 2024: revenue $6.00K (down 72.7% year over year), net income −$402, EPS −$0.01
• Quarter ended Dec 31, 2023 (from the annual report): revenue $32.0K, net income −$386K, EPS −$0.01
• Quarter ended Sep 30, 2023: revenue $0 (down 100.0% year over year), net income −$677K, EPS −$0.01
• Quarter ended Jun 30, 2023: revenue $44.0K (up 780.0% year over year), net income −$1.56M, EPS −$0.03
• Quarter ended Mar 31, 2023: revenue $22.0K (up 340.0% year over year), net income −$869K, EPS −$0.02
• Quarter ended Dec 31, 2022 (from the annual report): revenue $0 (down 100.0% year over year), net income −$1.81M, EPS −$0.03
• Quarter ended Sep 30, 2022: revenue $3.00K (down 84.2% year over year), net income −$1.10M, EPS −$0.03
• Quarter ended Jun 30, 2022: revenue $5.00K (up 150.0% year over year), net income −$926K, EPS −$0.04
• Quarter ended Mar 31, 2022: revenue $5.00K, net income −$507K, EPS −$0.05
• Quarter ended Dec 31, 2021 (from the annual report): revenue $60.0K, net income −$587K, EPS −$0.05
• Quarter ended Sep 30, 2021: revenue $19.0K, net income $68.0K, EPS $0.00

GTHP cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$1.07M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$1.12M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$1.75M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$1.48M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$1.59M, share buybacks n/a

GTHP balance sheet

• Jun 30, 2026: cash n/a, total assets $1.20M, total liabilities $6.96M, shareholders' equity −$5.76M
• Mar 31, 2026: cash n/a, total assets $1.60M, total liabilities $6.78M, shareholders' equity −$5.18M
• Dec 31, 2025: cash n/a, total assets $1.32M, total liabilities $7.33M, shareholders' equity −$6.01M
• Sep 30, 2025: cash n/a, total assets $903K, total liabilities $6.55M, shareholders' equity −$5.65M
• Jun 30, 2025: cash n/a, total assets $940K, total liabilities $6.41M, shareholders' equity −$5.47M
• Mar 31, 2025: cash n/a, total assets $967K, total liabilities $6.00M, shareholders' equity −$5.03M
• Dec 31, 2024: cash n/a, total assets $1.38M, total liabilities $6.27M, shareholders' equity −$4.89M
• Sep 30, 2024: cash n/a, total assets $1.25M, total liabilities $6.17M, shareholders' equity −$4.92M

What is GTHP's revenue?

GUIDED THERAPEUTICS INC reported $650K of revenue over its last four quarters, through June 30, 2026.

Is GTHP profitable?

No. GUIDED THERAPEUTICS INC lost $3.06M over the last four quarters.

What is GTHP's EPS?

Diluted earnings per share over the last four quarters were −$0.04; −$0.01 in the latest quarter.

GTHP ownership and insider trades · All stocks